Neo Kuma Ventures
Overview
Neo Kuma Ventures is a venture capital firm based in London, United Kingdom, that invests in early-stage psychedelic healthcare companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Monument Therapeutics | Jul 2021 | Seed | Lead |
| Mindstate Design Labs | Feb 2022 | Seed | Co-investor |
| Neurocentrx Pharma | May 2022 | VC Round | Co-investor |
| TRIPP, Inc. | Jun 2021 | Series A | Co-investor |
| Wavepaths | Nov 2021 | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Neo Kuma Ventures based?
Neo Kuma Ventures is headquartered in London, United Kingdom.
When was Neo Kuma Ventures founded?
Neo Kuma Ventures was founded in 2020.
How many portfolio companies does Neo Kuma Ventures have?
Neo Kuma Ventures has 7 portfolio companies in Caplight's dataset.
What are some companies in Neo Kuma Ventures's portfolio?
Portfolio companies visible on Caplight include Monument Therapeutics, Mindstate Design Labs, Neurocentrx Pharma, TRIPP, Inc., Wavepaths.
What was Neo Kuma Ventures's most recent investment shown here?
Neo Kuma Ventures's most recent investment in this portfolio sample was in Neurocentrx Pharma in 2022.
What sectors does Neo Kuma Ventures focus on?
Neo Kuma Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech, Media, Entertainment & Gaming, Enterprise Software.
What company stages does Neo Kuma Ventures focus on?
Neo Kuma Ventures typically invests at the Early stage.
What is Neo Kuma Ventures's AUM?
Neo Kuma Ventures's assets under management are estimated at over $25.4M.